Prevalence of hepatitis B and hepatitis C viruses in human urban population of Bahawalpur district, Pakistan

Journal of Medical Sciences

Volumn 6, Issue 3, 2006, Pages 367-373

  Rifat uz Zaman, ^a  

^a THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

Author keywords

Blood transfusions; Hepatitis B; Hepatitis C; Population; Sexual health; Virus

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD SAMPLING; CHROMATOGRAPHY; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HEALTH EDUCATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PATIENT CARE; PATIENT SELECTION; POPULATION RESEARCH; PREVALENCE; URBAN POPULATION;

EID: 33745738168     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.367.373     Document Type: Article

References (33)

1. Ahmad, J., A. S. Taj, A. Rahim, A. Shah and M. Rehman, 2004. Frequency of hepatitis B and hepatitis C in healthy blood donors of NWFP: A single center experience, 18: 343-352.
2. Alter, M.J., S.C. Hadier and H.S. Margolis et al., 1990. The changing epidemiology of hepatitis B in the United States: Needs for alternative vaccination strategies. JAMA, 263: 1218-1222.
3. Beasley, R.P. and L.Y. Hwang, 1983. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J. Infect. Dis., 147: 185-190.
4. Beasley, R.P. and L.Y. Hwang, 1984. Epidemiology of Hepatocellular Carcinoma. In: Vyas, G.N., J.L. Diestag and J.H. Hoofnagle (Eds.). Viral Hepatitis and Liver Disease. New York: Grane and Stratton, pp: 209-224.
5. Blumberg, B. S., 1971. The discovery of Australian antigen and its relation to viral hepatitis. Vitro, 7: 223.
6. CDC, 1990. Protection against viral hepatitis: Recommendations of the Immunization Practice Advisory Committee (ACIP), MMWR, 39: 8-22.
7. CDC, 2005. Transmission of Hepatitis B Virus Among Persons Undergoing Blood Glucose Monitoring in Long-Term-Care Facilities-Mississippi, North Carolina and Los Angeles County, California. MMWR, 54: 220-223.
8. El-Serag, H.B., J.A. Davila, N.J. Petersen and K.A. McGlynn, 2003. The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann. Intl. Med., 139: 817-823.
9. Fattovich, G., G. Giustina and S.W. Schalm, 1995. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology, 21: 77-82.
10. Gow, P.J. and D. Mutimer, 2001. Treatment of chronic hepatitis. BMJ, 323Z: 1164-1167.
11. Hoonagle, J.H., 1989. Type D (delta) hepatitis. JAMA, 261: 1321-1325.
12. Hoonagle, J.H., M. Adran and D. Bisceglie, 1997. The treatment of chronic vital hepatitis. The New England J. Med., 336: 347-355.
13. Houghton, M., Q.I. Choo and G. Kuo et al., 1994. The Hepatitis C Virus: Genetic Organization, Persistence and Vaccine Strategies. In: Nishioka, K, H. Suzuki, S. Mishiro and T, Oda (Eds.). Viral Hepatitis and Liver Disease. Tokyo: Springer Verlag, pp: 33-37.
14. Lau, J.Y.N. and T.L. Wright, 1993. Molecular virology and pathogenesis of hepatitis B. Lancet, 342: 1335-1340.
15. Linnen, J., J. Wages and Jr. Zang-Keek Z.Y. et al., 1996. Molecular cloning and disease association of hepatitis G virus: A transfusion transmissible agent. Science, 271: 505-508.
16. Lemon, S.M. and M.J. Alter, 1999. Viral Hepatitis. In: Holmes, K.K. et al. (Eds.). Sexually Transmitted Diseases. 3rd Edn., New York: McGraw-Hill.
17. Lauer, G.M. and B.D. Walker, 2001. Hepatitis C virus infection. N. Eng. J. Med., 345: 41-52.
18. Lok, A.S. and B.J. McMahon, 2001. Chronic hepatitis B. Hepatology, 34: 1225-1241.
19. Pianko, S. and J. McHutchison, 2000. Retreatment of hepatitis C patients who do not respond to interferon: The search continues. Am. J. Gastroenterol., 95:1122-1124.
20. Remis, R., 1998. Estimating the number of blood transfusion recipients infected by hepatitis virus in Canada. Canadian Blood Secretariat, pp: 1-52.
21. Rischitelli, G., J. Harris and L. McCauley et al., 2001. The risk of acquiring hepatitis B or C among public safety workers: A systematic review. Am. J. Prev. Med., 20: 299-306.
22. Rizzetto, M., 1983. The delta agent. Hepatology, 3: 729-737.
23. Shah, F.U., M. Salah, I.A. Malik and I. Hussain, 2002. Increasing prevalence of chronic hepatitis and associated risk factors. Pak. J. Med., 4: 2.
24. Siegl, G., 2004. Hepatitis A and E enterically transmitted virus infections of the liver. Ther Umsch, 61:481-486.
25. Stevens, C.E., P.T. Toy and M.J. Tong, 1985. Perinatal hepatitis B virus transmission in the United States: Prevention by passive-active immunization. JAMA, 253: 5-40.
26. Takahashi, M., G. Yamada, R. Miyamoto, T. Doi, H. Endo and T. Tsuji, 1993. Natural courde of chronic hepatitis. Am. I. Gastroenterol., 88: 240-243.
27. Tassaduqe, K., M. Ali, A. Salam, H. Kalsoom, A. Salam and S. Umar, 2004. Studies on the Prevalence of Hepatitis B Virus in Relation to Sex, Age, Promotive Factors, Associated Symptoms and Season Among Human Urban Population of Multan. Pak. J. Med. Sci., 4: 183-187.
28. US Department of Labor, US Department of Health and Human Services, 1987. Joint Advisory Notice. Protection against exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Federal Register, 52:41818-41824.
29. Valla, D., 2003. EASL International Consensus Conference on Hepatitis B, Consensus statement (Short version). J. Hepatol., 38: 533-540.
30. Watanabe, H.E. and N. Ikeda, 2002. Association between HBV genotype and development of hepatocellular carcinoma (Poster # T1354). Gastroenterology, pp: 215.
31. Wilber, J.C., 1993. Development and use of laboratory tests for hepatitis C infection: A review. J. Clin. Immonoassay, 16: 204.
32. WHO, 2000. Hepatitis B. World Health Organization Fact Sheet, pp: 204.
33. Yeung, L.T., S.M. King and E.A. Roberts, 2001. Mother-to-infant transmission of hepatitis C virus. Hepatology, 34: 223-229.